Mucinous glycoprotein (muc-1) vaccine

Details Mucinous glycoprotein (muc-1) vaccine Mucinous glycoprotein (muc-1) vaccine

A - Human Necessities

61

K

A61K 39/00 (2006.01) A61K 38/17 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2562990

The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1 based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.

La présente invention concerne une méthode destinée au traitement d'un individu atteint d'un cancer, tel que le cancer bronchique non à petites cellules ou le cancer de la prostate, consistant à administrer à cet individu une préparation à base de MUC-1. Cette préparation peut être une préparation de vaccin liposomal à base de MUC-1.

Affiliated with

Also associated with

Rating

Mucinous glycoprotein (muc-1) vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mucinous glycoprotein (muc-1) vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mucinous glycoprotein (muc-1) vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2081928